Trials / Active Not Recruiting
Active Not RecruitingNCT07018453
A Study Comparing SHR-3167 and Insulin Degludec in Type 2 Diabetic Subjects Treated With Basal Insulin With or Without Oral Antidiabetic Drugs
A Randomized, Open-label, Treat-to-target, Parallel-Controlled Phase II Clinical Study Investigating the Efficacy and Safety of SHR-3167 and Insulin Degludec in Type 2 Diabetic Subjects Treated With Basal Insulin With or Without Oral Antidiabetic Drugs
- Status
- Active Not Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 173 (actual)
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the glycemic control and safety of SHR-3167 and Insulin Degludec in type 2 diabetic participants treated with basal insulin with or without oral antidiabetic drugs.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SHR-3167 | SHR-3167 Injection. |
| DRUG | Insulin Degludec | Insulin Degludec Injection. |
Timeline
- Start date
- 2025-07-16
- Primary completion
- 2026-02-01
- Completion
- 2026-05-01
- First posted
- 2025-06-12
- Last updated
- 2025-11-18
Locations
2 sites across 1 country: China
Source: ClinicalTrials.gov record NCT07018453. Inclusion in this directory is not an endorsement.